Arylsulfatase A: An Important Metabolic Factor in Pathophysiology of Different Diseases

1. Barth M L, Ward C, Harris A, Saad A, Fensom A.- Frequency of arylsulphatase A pseudodeficiency associated mutations in a healthy population. J Med Genet, 1994;31:667-671.10.1136/jmg.31.9.66710500737815433Search in Google Scholar

2. Ramakrishnan H, Hedayati KK. Increasing sulfatide synthesis in myelin forming cells of arylsulfatase A deficient mice causes demyelinisation and neurological symptoms reminiscent of human metachromatic leucodystophy. J Neurosci, 2007;27:9482-9490.10.1523/JNEUROSCI.2287-07.2007667312517728461Search in Google Scholar

3. Takahasi T, Murakami K, et al. Sulfatide is required for efficient replication of Influenza A virus. J Virol, 2008;82:5940-5950.10.1128/JVI.02496-07239512718417587Search in Google Scholar

4. Fazakas Z, Tilinca M, Nemes-Nagy E, et al. Arylsulphatase A – A possible important determinant in the pathophysiology of metabolic and neuropsychiatric diseases. Annals of RSBC, 2013;1:80-84.Search in Google Scholar

5. Thomas GH. Commentary “Pseudodeficiencies” od lysosomal hydrolases. Am J Hum Genet, 1994; 54:934-940.Search in Google Scholar

6. Wenger D, Louie E. Pseudodeficiencies of arylsulfatase A and galactocerebrosidase activities. Dev Neurosci, 1991;13:216-221.10.1159/0001121631687777Search in Google Scholar

7. Buschard K, Blomqvist V, Osterbye T, Fredman P. Involvement of sulfatide in beta cells and type 1 and type 2 diabetes. Diabetologia, 2005;48:1957-1962.10.1007/s00125-005-1926-916143863Search in Google Scholar

8. Martinelli P, Ippoliti M, Montanari M, et al. Arylsulphatase A (ASA) activity in parkinsonism and symptomatic essential tremor. ActaNeurolScand, 1994;89:171-174.10.1111/j.1600-0404.1994.tb01656.x7913281Search in Google Scholar

9. Hu R, Li G, Kamijo Y. Serum sulfatides as a novel biomarker for cardiovascular disease in patients with end-stage renal failure. Glicoconj J, 2007;24:565-571.10.1007/s10719-007-9053-017657603Search in Google Scholar

10. Zhang X, Nakajima T, Kamijo Y, et al. Acute kidney injury induced by protein overload nephropathy down-regulates gene expression of hepatic cerebroside sulfotransferase in mice, resulting in reduction of liver and serum sulfatides, Biochem Biophys Res Commun, 2009;390:1382-1388.Search in Google Scholar

11. Han X, Holtzman D, Mckeel DW. Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer’s disease: potential role in disease pathogenesis, J Neurochem, 2002;82:809-818.Search in Google Scholar

12. Cheng H, Xu J, McKeel DW. Specificity and potential mechanism of sulfatide deficiency in Alzheimer’s disease: an electrospray ionization mass spectrometric study, Cel Mol Biol; 2003;49:809-818.Search in Google Scholar

13. Petratos S, Turnbull VJ, Papadopoulos R, Ayers M, Gonzales MF – Antibodies against peripheral myelin glycolipids in people with HIV infection. Immun Cell Biol, 1998;76:535-541.10.1046/j.1440-1711.1998.00778.x9893031Search in Google Scholar

14. Purohit A, Foster PA. Steroid sulfatase inhibitors for estrogen- and androgen-dependent cancers. J Endocrinol. 2012;212:99-110.10.1530/JOE-11-026621859802Search in Google Scholar

15. Bhattacharyya S, Tobacman JK. Steroid sulfatase, arylsulfatases A and B, galactose-6-sulfatase, and iduronate sulfatase in mammary cells and effects of sulfated and non-sulfated estrogens on sulfatase activity. J Steroid Biochem Mol Biol. 2007;103:20-34.10.1016/j.jsbmb.2006.08.00217064891Search in Google Scholar